Jianyi Ma

Title: Inventor Jianyi Ma: Innovating Pharmaceutical Chemistry in Hubei, China

Introduction

Jianyi Ma is a notable inventor based in Hubei, China, with a significant contribution to the field of pharmaceutical chemistry. His innovative work has led to the development of a patent that showcases the potential for improved therapeutic effects in hypertension treatment.

Latest Patents

Jianyi Ma holds a patent for "Benzimidazole derivatives and preparation process and pharmaceutical uses thereof." This invention specifically focuses on benzimidazole derivatives, including Ligustrazine and NO donor derivatives. The compounds are designed to rapidly release Ligustrazine or nitric oxide (NO) in vivo. They exhibit effective synergetic effects with Azilsartan, thereby enhancing the anti-hypertension effect while minimizing adverse effects. Additionally, the released Ligustrazine provides ideal protection to patients' livers and kidneys, addressing gaps in existing treatments.

Career Highlights

Throughout his career, Jianyi Ma has worked with notable companies such as Wuhan LL Science and Technology Development Co., Ltd. and Wuhan QR Pharmaceuticals Co., Ltd. His tenure at these organizations has been marked by significant contributions to pharmaceutical research and development, particularly in creating advanced therapeutic compounds.

Collaborations

Jianyi Ma has collaborated with distinguished coworkers, including Jian Ge and Guangya Xiang. These partnerships have fostered a creative environment that encourages innovation and the advancement of pharmaceutical sciences.

Conclusion

With one patent to his name and ongoing collaborative efforts, Jianyi Ma continues to make strides in the pharmaceutical industry. His work on benzimidazole derivatives represents a promising advancement in hypertension treatment, enhancing patient outcomes and filling essential gaps in prior art. As he advances his career, Jianyi Ma remains a pivotal figure in the landscape of pharmaceutical innovation.